These aberrantly expressed glycoproteins, including MUC1, MUC4, and MUC13 play important roles in tumor progression and treatment and are commonly referred to as tumor-related glycoproteins (Dhanisha et al., 2018). This evidence concerns the gene MUC4 and neoplasm.